Capital Fund Management (CFM)
BSX icon

Capital Fund Management (CFM)’s Boston Scientific BSX Stock Holding History

Capital Fund Management (CFM)’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.4M Sell
1,486,096
-179,851
-11% -$9.77M 0.28% 49
2026
Q1 		$105M Buy
1,665,947
+513,899
+45% +$41.1M 0.47% 17
2025
Q4 		$110M Buy
1,152,048
+612,642
+114% +$60.1M 0.31% 33
2025
Q3 		$52.7M Buy
+539,406
New +$55.9M 0.14% 180
2025
Q2 		– Sell
-25,599
Closed -$2.59M – 2348
2025
Q1 		$2.58M Buy
+25,599
New +$2.58M 0.01% 1311
2021
Q3 		– Sell
-29,022
Closed -$1.24M – 1523
2021
Q2 		$1.24M Buy
+29,022
New +$1.22M 0.01% 1100
2021
Q1 		– Sell
-647,240
Closed -$23.3M – 1289
2020
Q4 		$23.3M Buy
+647,240
New +$23.3M 0.22% 114
2020
Q2 		– Sell
-549,999
Closed -$17.9M – 1076
2020
Q1 		$17.9M Buy
+549,999
New +$21.5M 0.28% 102
2019
Q1 		– Sell
-35,152
Closed -$1.24M – 1680
2018
Q4 		$1.24M Buy
+35,152
New +$1.27M 0.01% 1032
2018
Q2 		– Sell
-18,615
Closed -$561K – 1988
2018
Q1 		$509K Sell
18,615
-518,654
-97% -$14.1M ﹤0.01% 1456
2017
Q4 		$13.3M Buy
+537,269
New +$14.8M 0.07% 326
2017
Q2 		– Sell
-523,318
Closed -$13M – 1470
2017
Q1 		$13M Buy
523,318
+440,717
+534% +$10.7M 0.11% 237
2016
Q4 		$1.79M Buy
82,601
+36,864
+81% +$804K 0.02% 800
2016
Q3 		$1.09M Buy
+45,737
New +$1.09M 0.01% 936
2015
Q3 		– Sell
-37,900
Closed -$671K – 1422
2015
Q2 		$671K Buy
+37,900
New +$677K 0.01% 970
2014
Q4 		– Sell
-11,900
Closed -$141K – 1583
2014
Q3 		$141K Sell
11,900
-784,478
-99% -$9.88M ﹤0.01% 1472
2014
Q2 		$10.2M Sell
796,378
-972,869
-55% -$12.7M 0.11% 227
2014
Q1 		$23.9M Sell
1,769,247
-352,570
-17% -$4.63M 0.29% 62
2013
Q4 		$25.5M Buy
2,121,817
+2,030,305
+2,219% +$24M 0.32% 39
2013
Q3 		$1.07M Sell
91,512
-102,127
-53% -$1.1M 0.01% 844
2013
Q2 		$1.79M Buy
+193,639
New +$1.64M 0.03% 657

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Fund Management (CFM)'s BSX Position: Q2 2026 in Review

Capital Fund Management (CFM) reduced its Boston Scientific (BSX) stake by 11% in Q2 2026, selling an estimated $9.77M and leaving 1,486,096 shares worth $63.4M. The position accounts for 0.28% of the portfolio, ranked #49.

Capital Fund Management (CFM) first reported a position in BSX in Q2 2013 and has held it in 21 quarters since. The position peaked at $110M in Q4 2025. 1,476 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Capital Fund Management (CFM) held 1,486,096 shares of Boston Scientific worth $63.4M as of Q2 2026.
  • Capital Fund Management (CFM) sold 179,851 Boston Scientific shares in Q2 2026, an estimated $9.77M.
  • Boston Scientific made up 0.28% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #49 holding.
  • Capital Fund Management (CFM) first reported a position in Boston Scientific in Q2 2013 and has held it in 21 quarters since.
  • Capital Fund Management (CFM)'s Boston Scientific position peaked at $110M in Q4 2025.
  • 1,476 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.